Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-03-24-Speech-2-259"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090324.26.2-259"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"(
) We are reluctantly voting in favour of the new regulation on cosmetic products, despite the fact that it opens up the way for derogations from the prohibition on the use of carcinogenic CMR substances. Fortunately, Parliament has limited this possibility by requiring the global exposure to CMR substances from all routes and sources to be taken into account during the approval process. The adoption of the regulation means that, in Denmark, we cannot prohibit substances that we already know to be carcinogens, hormone disrupters or allergens, as this would be seen as a barrier to the free movement of goods, which is precisely what the legislation is intended to ensure.
This is counterbalanced, however, by Parliament’s introduction of the regulation of nanoparticles and thus the application of the precautionary principle. From now on it must be demonstrated that the nanoparticles are not harmful before they are permitted to be used, rather than having to prove that they are harmful before their use can be prevented, which, in practice, is the prevailing principle in EU legislation.
The regulation also introduces more stringent requirements for detailed product descriptions."@en1
|
| lpv:unclassifiedMetadata |
"DA"1
|
Named graphs describing this resource:
The resource appears as object in 2 triples